BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10833298)

  • 1. [Beyond type I spinal atrophy].
    Mastella C
    Assist Inferm Ric; 1999; 18(4):240-6. PubMed ID: 10833298
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival of patients with spinal muscular atrophy type 1.
    Gregoretti C; Ottonello G; Chiarini Testa MB; Mastella C; Ravà L; Bignamini E; Veljkovic A; Cutrera R
    Pediatrics; 2013 May; 131(5):e1509-14. PubMed ID: 23610208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetics of the spinal muscular atrophies.
    Baraitser M
    Prog Clin Biol Res; 1989; 306():75-84. PubMed ID: 2662214
    [No Abstract]   [Full Text] [Related]  

  • 4. Spinal muscular atrophy: recent advances and future prospects.
    Nicole S; Diaz CC; Frugier T; Melki J
    Muscle Nerve; 2002 Jul; 26(1):4-13. PubMed ID: 12115944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COUNTERPOINT: Is Noninvasive Ventilation Always the Most Appropriate Manner of Long-term Ventilation for Infants With Spinal Muscular Atrophy Type 1? No.
    Panitch HB
    Chest; 2017 May; 151(5):965-968. PubMed ID: 27989616
    [No Abstract]   [Full Text] [Related]  

  • 6. Tracheotomy and children with spinal muscular atrophy type 1: ethical considerations in the French context.
    Rul B; Carnevale F; Estournet B; Rudler M; Hervé C
    Nurs Ethics; 2012 May; 19(3):408-18. PubMed ID: 22323397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome measures in spinal muscular atrophy.
    Montes J; Gordon AM; Pandya S; De Vivo DC; Kaufmann P
    J Child Neurol; 2009 Aug; 24(8):968-78. PubMed ID: 19509409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POINT: Is Noninvasive Ventilation Always the Most Appropriate Manner of Long-term Ventilation for Infants With Spinal Muscular Atrophy Type 1? Yes, Almost Always.
    Bach JR
    Chest; 2017 May; 151(5):962-965. PubMed ID: 27989614
    [No Abstract]   [Full Text] [Related]  

  • 9. [Spinal muscular atrophy].
    Porro G; Carboni P
    Riv Neurol; 1988; 58(2):45-9. PubMed ID: 3051286
    [No Abstract]   [Full Text] [Related]  

  • 10. Survival probabilities of patients with childhood spinal muscle atrophy.
    Mannaa MM; Kalra M; Wong B; Cohen AP; Amin RS
    J Clin Neuromuscul Dis; 2009 Mar; 10(3):85-9. PubMed ID: 19258855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vital capacity in spinal muscular atrophy.
    Bach JR; Tuccio MC; Khan U; Saporito LR
    Am J Phys Med Rehabil; 2012 Jun; 91(6):487-93. PubMed ID: 22469873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal muscular atrophies.
    Lancet; 1990 Aug; 336(8710):280-1. PubMed ID: 1973974
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy and rehabilitation of the floppy infant.
    Eng GD
    R I Med J (1976); 1989 Oct; 72(10):367-70. PubMed ID: 2595191
    [No Abstract]   [Full Text] [Related]  

  • 14. Laparoscopic Nissen fundoplication during gastrostomy tube placement and noninvasive ventilation may improve survival in type I and severe type II spinal muscular atrophy.
    Yuan N; Wang CH; Trela A; Albanese CT
    J Child Neurol; 2007 Jun; 22(6):727-31. PubMed ID: 17641258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversy over Werdnig-Hoffmann disease and multiple system atrophy.
    Chou SM
    Curr Opin Neurol; 1993 Dec; 6(6):861-4. PubMed ID: 8293160
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene-Targeted Therapies and Palliative Care in Children with Spinal Muscular Atrophy Type I: No Intrinsic Contradiction.
    von der Hagen M; Nolte-Buchholtz S; Janisch M; Pietz J; Blankenburg M; Ziegler A
    J Palliat Med; 2021 Feb; 24(2):162-163. PubMed ID: 33522861
    [No Abstract]   [Full Text] [Related]  

  • 17. Spinal muscular atrophy with respiratory distress type 1 (SMARD1).
    Kaindl AM; Guenther UP; Rudnik-Schöneborn S; Varon R; Zerres K; Schuelke M; Hübner C; von Au K
    J Child Neurol; 2008 Feb; 23(2):199-204. PubMed ID: 18263757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of thyrotropin-releasing hormone in the treatment of spinal muscular atrophy.
    Takeuchi Y; Miyanomae Y; Komatsu H; Oomizono Y; Nishimura A; Okano S; Nishiki T; Sawada T
    J Child Neurol; 1994 Jul; 9(3):287-9. PubMed ID: 7930408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of type I spinal muscular atrophy in North Dakota.
    Burd L; Short SK; Martsolf JT; Nelson RA
    Am J Med Genet; 1991 Nov; 41(2):212-5. PubMed ID: 1785637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and mutational characteristics of spinal muscular atrophy with respiratory distress type 1 in The Netherlands.
    Stalpers XL; Verrips A; Poll-The BT; Cobben JM; Snoeck IN; de Coo IF; Brooks A; Bulk S; Gooskens R; Fock A; Verschuuren-Bemelmans C; Sinke RJ; de Visser M; Lemmink HH
    Neuromuscul Disord; 2013 Jun; 23(6):461-8. PubMed ID: 23566544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.